AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 FEB 14 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Hematopoietic stem cell grafts processed to minimize the number of CD34[superscript]- cells can improve recovery in advanced breast cancer patients undergoing high-dose chemotherapy (HDC), according to researchers in the United States.
J.L. Klein and colleagues working at Wayne State University's Barbara Ann Karmanos Cancer Center in Detroit, Michigan, evaluated the safety and efficacy of autologous, CD34-enriched stem cell grafts in women suffering from breast cancer with bone or bone marrow metastases.
Enriched stem cell grafts enabled quick hematological recovery from intense myeloablative chemotherapy, Klein and coauthors found.
A cohort of 50 volunteers underwent peripheral blood progenitor cell (PBPC) transplantation using grafts comprising magnetically isolated CD34[superscript]+ cells. The autologous grafts were reinfused into patients 2 days after HDC with cyclophosphamide, cisplatin and carmustine, according to the report.
Patients achieved neutrophil recovery in an median of 9 days, study data showed, with transfusion-independent platelet recovery seen in a median of 11 days. The most common form of morbidity was herpes zoster infection, seen in 23% of the patients studied.
The overall and progression-free ...
Source: HighBeam Research, CD34-Enriched Stem Cell Grafts Hasten Recovery After Myeloablative...